Tag Archives: is

Living robots powered by muscle

The robot is a dramatic example of the marriage of biotechnology with nanotechnology

Tiny robots powered by living muscle have been created by scientists at the University of California, Los Angeles.

The devices were formed by “growing” rat cells on microscopic silicon chips, the researchers report in the journal Nature Materials.

Less than a millimetre long, the miniscule robots can move themselves without any external source of power.

The work is a dramatic example of the marriage of biotechnology with the tiny world of nanotechnology.

In nanotechnology, researchers often turn to the natural world for inspiration.

But Professor Carlo Montemagno, of the University of California, Los Angeles, turns to nature not for ideas, but for actual starting materials.

In the past he has made rotary nano-motors out of genetically engineered proteins. Now he has grown muscle tissue onto tiny robotic skeletons.

Living device

Montemano’s team used rat heart cells to create a tiny device that moves on its own when the cells contract. A second device looks like a minute pair of frog legs.

“The bones that we’re using are either a plastic or they’re silicon based,” he said. “So we make these really fine structures that mechanically have hinges that allow them to move and bend.

“And then by nano-scale manipulation of the surface chemistry, the muscle cells get the cues to say, ‘Oh! I want to attach at this point and not to attach at another point’. And so the cells assemble, then they undergo a change, so that they actually form a muscle.

“Now you have a device that has a skeleton and muscles on it to allow it to move.”

Under a microscope, you can see the tiny, two-footed “bio-bots” crawl around.

Professor Montemagno says muscles like these could be used in a host of microscopic devices – even to drive miniature electrical generators to power computer chips.

But when biological cells become attached to silicon – are they alive?

“They’re absolutely alive,” Professor Montemagno told BBC News. “I mean the cells actually grow, multiply and assemble – they form the structure themselves. So the device is alive.”

The notion is likely to disturb many who already have concerns about nanotechnology.

But for Carlo Montemagno, a professor of engineering, it makes sense to match the solutions that nature has already found through billions of years of evolution to the newest challenges in technology.

For Heart Health, Focus on Risk Factors

For Heart Health, Focus on Risk Factors

Treating multiple factors that contribute to heart attack risk is better than simply focusing on lowering a patient’s cholesterol level, according to U.S. researchers.

“We’ve been worrying too much about people’s cholesterol level and not enough about their overall risk of heart disease,” Dr. Rodney A. Hayward, director of the Veterans Affairs Center for Health Services Research and Development, and a professor of internal medicine at the University of Michigan Medical School, said in a news release.

Levels of harmful LDL cholesterol should be less than 130 for most people and less than 70 for high-risk patients, according to the National Cholesterol Education Program.

In their study, Hayward and his colleagues analyzed data from Americans, aged 30 to 75, with no history of heart attack, who took part in clinical trials of cholesterol-lowering statin drugs. The researchers evaluated the benefit of five years of treatment tailored to a patient’s overall heart attack risk based on factors such as age, family history, diabetes, high blood pressure, smoking status and C-reactive protein level.

The results showed that the tailored treatment was more efficient (more benefit per person treated) and prevented substantially more heart attacks, strokes and cardiovascular deaths than simply reducing cholesterol to a certain target. The tailored treatment saved 500,000 more quality-adjusted life years than cholesterol-focused therapy, the researchers said.

“The bottom line message — knowing your overall heart attack risk is more important than knowing your cholesterol level. If your overall risk is elevated, you should probably be on a statin regardless of what your cholesterol is, and if your risk is very high, [you] should probably be on a high dose of statin,” Hayward said in the news release.

“However, if your LDL cholesterol is high, but your overall cardiac risk is low, taking a statin does not make sense for you. If your cholesterol is your only risk factor and you’re younger, you should work on diet and exercise,” he added.

The study was published online Jan. 18 in the Annals of Internal Medicine.
heart health diet,women heart health,heart health month,heart health,heart health tips,heart health exercise,heart disease health,heart health recipes,heart health online,heart health information,heart health news,heart health program,heart health cholesterol,heart health symptoms,heart health risk,aspirin heart health,heart health risks,heart health stress,women’s heart health,heart attack health,heart health monitor,heart health food,heart health center,heart health product,heart health quiz,heart health risk factors,diabetes heart health,heart and health,improve heart health,womens heart health,your heart health,heart health products,american heart health,heart health nutrition,national heart health,february heart health,heart health awareness,heart health foods,heart health diets,dental health heart disease,heart health system,wine heart health,heart health supplement,heart health pack,heart health poster,heart health seminar,heart health posters,silk heart health,heart health blog,heart health blogs,heart health tip,heart health website,search heart health,support heart health

Fast-acting impotency drug outpaces rivals: study

Fast-acting impotency drug outpaces rivals: study

Biotech firm Vivus unveiled a would-be player Monday in the 3.7-billion-dollar erectile dysfunction market: avanafil, effective in just 15 minutes, far faster than blockbuster rivals Viagra and Cialis.

“The magnitude of success in the first 15 minutes was surprising,” Leland Wilson, the company’s CEO, said in a statement.

Wilson put the spotlight on upbeat results for the class three investigational drug to treat male impotency, now in its last step before it can get a green light from the Food and Drug Administration (FDA).

“This new data further strengthens the profile and differentiation of avanafil from other currently available oral ED therapies,” Wilson said, referring to erectile dysfunction.

While “we knew from the pharmacokinetic profile that avanafil works very quickly, this data is exciting evidence of how fast avanafil really works,” he stressed.

“From our discussions with patients and physicians, we knew that rapid onset was an important attribute in the selection of an ED therapy,” he added.

Knowing avanafil acts in 15 minutes and lasts the length of a sexual encounter should be huge pluses for the drug in this highly lucrative market, said Dr Charles Bowden with Vivus.

The company is eyeing a market launch in early 2012.

Pfizer, which makes Viagra, says its drug acts within 30 minutes to an hour after it is taken. Cialis, made by Eli Lilly, starts working from 30 minutes to six hours after ingestion.

A third competitor, Levitra, acts starting between 25 and 60 minutes after it is taken.

impotency drug environmental health,impotency drug health department,impotency drug health insurance,impotency drug health nutrition,health,impotency drug public health,impotency drug health risk assessment,impotency drug health plans,impotency drug health dept,impotency drug health benefits,impotency drug health education,impotency drug health promotion,natural health,health policy,department of health,women’s health,health diet,impotency drug health products,impotency drug skin health,impotency drug health supplements,impotency drug human health,impotency drug health concerns,impotency drug insurance health,impotency drug dental health,impotency drug health coverage,impotency drug health center,impotency drug gov health,impotency drug health departments,impotency drug health county,impotency drug womens health,impotency drug health effects,health regulations,board of health,nutritional health,clinics health,nutrition and health,nutrients health,current health,google health,total health,health